Psyllium supplementation and lipid profiles: systematic review and dose-response meta-analysis of randomized controlled trials

车前子补充剂与血脂谱:随机对照试验的系统评价和剂量反应荟萃分析

阅读:1

Abstract

BACKGROUND: Some studies indicate that psyllium supplementation may change lipid profile levels. This study assessed the impact of psyllium consumption on lipid profile (Low-Density Lipoprotein Cholesterol, Triglyceride, High-Density Lipoprotein Cholesterol, and cholesterol). MAIN TEXT: We started searching articles using Scopus, Institute for Scientific Information Web of Science, and PubMed to identify eligible publications from March 15, 2022 to August 2, 2025. The effect of psyllium on lipid profiles in adults was evaluated through Randomized Controlled Trials. We calculated Weighted Mean Differences with 95% Confidence Intervals using a random effects model. In this study, 41 Randomized Controlled Trials articles and 2049 participants were included. Psyllium showed a significant decrease in Low-Density Lipoprotein Cholesterol and total Cholesterol, a nonsignificant reduction in Triglyceride, and an insignificantly increase in High-Density Lipoprotein Cholesterol; cholesterol: (Weighted Mean Differences: -9.05; 95% Confidence Intervals: -13.71, -4.40; p-value < 0.05), High-Density Lipoprotein Cholesterol: (Weighted Mean Differences: 0.57; 95% Confidence Intervals: -0.88, 2.04; p-value > 0.05), Triglyceride: (Weighted Mean Differences: -5.29; 95% Confidence Intervals: -12.14, 1.54; p-value > 0.05), and Low-Density Lipoprotein Cholesterol: (Weighted Mean Differences: -8.55; 95% Confidence Intervals: -12.92, -4.19; p < 0.001). Considerable heterogeneity was found for cholesterol: (I-squared index = 89.30%, p-value < 0.001), High-Density Lipoprotein Cholesterol: ( I-squared index = 77.96%, p-value < 0.001), Low-Density Lipoprotein Cholesterol: (I-squared index = 88.46%, p-value < 0.001); and Triglyceride: (I-squared index = 83.25%, p-value < 0.001) and duration and dosage of psyllium had a nonsignificant linear influence on lipid profiles. CONCLUSION: Results showed that psyllium can significantly decrease Low-Density Lipoprotein Cholesterol and total cholesterol, can insignificantly decrease triglyceride, and can insignificantly increase High-Density Lipoprotein Cholesterol following psyllium consumption. REGISTRATION: The study was approved by the Medical Ethics Committee of Isfahan University of Medical Sciences (IR.MUI. RESEARCH: REC.1402.017, Grant number: 140206). This research was registered in the PROSPERO system (CRD42023402987). CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。